Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.

Lee CG, Hartl D, Lee GR, Koller B, Matsuura H, Da Silva CA, Sohn MH, Cohn L, Homer RJ, Kozhich AA, Humbles A, Kearley J, Coyle A, Chupp G, Reed J, Flavell RA, Elias JA.

J Exp Med. 2009 May 11;206(5):1149-66. doi: 10.1084/jem.20081271. Epub 2009 May 4.

2.

The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury.

Sohn MH, Kang MJ, Matsuura H, Bhandari V, Chen NY, Lee CG, Elias JA.

Am J Respir Crit Care Med. 2010 Oct 1;182(7):918-28. doi: 10.1164/rccm.200912-1793OC. Epub 2010 Jun 17.

3.

Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema.

Matsuura H, Hartl D, Kang MJ, Dela Cruz CS, Koller B, Chupp GL, Homer RJ, Zhou Y, Cho WK, Elias JA, Lee CG.

Am J Respir Cell Mol Biol. 2011 Jun;44(6):777-86. doi: 10.1165/rcmb.2010-0081OC. Epub 2010 Jul 23.

4.

Role of breast regression protein-39/YKL-40 in asthma and allergic responses.

Lee CG, Elias JA.

Allergy Asthma Immunol Res. 2010 Jan;2(1):20-7. doi: 10.4168/aair.2010.2.1.20. Epub 2009 Dec 30.

5.

Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function.

Schmidt IM, Hall IE, Kale S, Lee S, He CH, Lee Y, Chupp GL, Moeckel GW, Lee CG, Elias JA, Parikh CR, Cantley LG.

J Am Soc Nephrol. 2013 Feb;24(2):309-19. doi: 10.1681/ASN.2012060579. Epub 2013 Jan 4.

6.

Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.

Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, He CH, Takyar S, Elias JA.

Annu Rev Physiol. 2011;73:479-501. doi: 10.1146/annurev-physiol-012110-142250. Review.

7.

Role of Chitinase 3-Like-1 in Interleukin-18-Induced Pulmonary Type 1, Type 2, and Type 17 Inflammation; Alveolar Destruction; and Airway Fibrosis in the Murine Lung.

Kang MJ, Yoon CM, Nam M, Kim DH, Choi JM, Lee CG, Elias JA.

Am J Respir Cell Mol Biol. 2015 Dec;53(6):863-71. doi: 10.1165/rcmb.2014-0366OC.

8.

Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD.

Sakazaki Y, Hoshino T, Takei S, Sawada M, Oda H, Takenaka S, Imaoka H, Matsunaga K, Ota T, Abe Y, Miki I, Fujimoto K, Kawayama T, Kato S, Aizawa H.

PLoS One. 2011;6(9):e24177. doi: 10.1371/journal.pone.0024177. Epub 2011 Sep 7.

9.

Differential expression and function of breast regression protein 39 (BRP-39) in murine models of subacute cigarette smoke exposure and allergic airway inflammation.

Nikota JK, Botelho FM, Bauer CM, Jordana M, Coyle AJ, Humbles AA, Stampfli MR.

Respir Res. 2011 Apr 7;12:39. doi: 10.1186/1465-9921-12-39.

10.

The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.

Hector A, Kormann MS, Mack I, Latzin P, Casaulta C, Kieninger E, Zhou Z, Yildirim AÖ, Bohla A, Rieber N, Kappler M, Koller B, Eber E, Eickmeier O, Zielen S, Eickelberg O, Griese M, Mall MA, Hartl D.

PLoS One. 2011;6(9):e24399. doi: 10.1371/journal.pone.0024399. Epub 2011 Sep 20.

11.

Exacerbation of experimental autoimmune encephalomyelitis in the absence of breast regression protein 39/chitinase 3-like 1.

Bonneh-Barkay D, Wang G, Laframboise WA, Wiley CA, Bissel SJ.

J Neuropathol Exp Neurol. 2012 Nov;71(11):948-58. doi: 10.1097/NEN.0b013e31826eaee7.

12.

Role for mammalian chitinase 3-like protein 1 in traumatic brain injury.

Wiley CA, Bonneh-Barkay D, Dixon CE, Lesniak A, Wang G, Bissel SJ, Kochanek PM.

Neuropathology. 2015 Apr;35(2):95-106. doi: 10.1111/neup.12158. Epub 2014 Nov 7.

PMID:
25377763
13.

Chitinase 3-like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation.

Ahangari F, Sood A, Ma B, Takyar S, Schuyler M, Qualls C, Dela Cruz CS, Chupp GL, Lee CG, Elias JA.

Am J Respir Crit Care Med. 2015 Apr 1;191(7):746-57. doi: 10.1164/rccm.201405-0796OC.

14.

A chitinase-like protein in the lung and circulation of patients with severe asthma.

Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, Dziura JD, Reed J, Coyle AJ, Kiener P, Cullen M, Grandsaigne M, Dombret MC, Aubier M, Pretolani M, Elias JA.

N Engl J Med. 2007 Nov 15;357(20):2016-27.

15.

Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease.

Zhou Y, He CH, Herzog EL, Peng X, Lee CM, Nguyen TH, Gulati M, Gochuico BR, Gahl WA, Slade ML, Lee CG, Elias JA.

J Clin Invest. 2015 Aug 3;125(8):3178-92. doi: 10.1172/JCI79792. Epub 2015 Jun 29.

16.

Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40.

Gomez JL, Crisafi GM, Holm CT, Meyers DA, Hawkins GA, Bleecker ER, Jarjour N; Severe Asthma Research Program (SARP) Investigators, Cohn L, Chupp GL.

J Allergy Clin Immunol. 2015 Jul;136(1):51-58.e10. doi: 10.1016/j.jaci.2014.11.027. Epub 2015 Jan 13.

17.

Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.

Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF Jr, Nicolae DL, Elias JA, Chupp GL.

N Engl J Med. 2008 Apr 17;358(16):1682-91. doi: 10.1056/NEJMoa0708801. Epub 2008 Apr 9.

18.

Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis.

Zhou Y, Peng H, Sun H, Peng X, Tang C, Gan Y, Chen X, Mathur A, Hu B, Slade MD, Montgomery RR, Shaw AC, Homer RJ, White ES, Lee CM, Moore MW, Gulati M, Lee CG, Elias JA, Herzog EL.

Sci Transl Med. 2014 Jun 11;6(240):240ra76. doi: 10.1126/scitranslmed.3007096.

19.

YKL-40/CHI3L1 drives inflammation on the road of tumor progression.

Libreros S, Iragavarapu-Charyulu V.

J Leukoc Biol. 2015 Dec;98(6):931-6. doi: 10.1189/jlb.3VMR0415-142R. Epub 2015 Aug 26. Review.

PMID:
26310833
20.

Chitinase-like proteins in lung injury, repair, and metastasis.

Lee CG, Dela Cruz CS, Ma B, Ahangari F, Zhou Y, Halaban R, Sznol M, Elias JA.

Proc Am Thorac Soc. 2012 May;9(2):57-61. doi: 10.1513/pats.201112-056MS.

Supplemental Content

Support Center